The patent owner of the EpiPen is the target of our wrath over its price. However, as I noted in a previous post, there is
Category: Healthcare
Not much is as important as health care and in America the debate rages on despite passage of the PPACA. What are the ongoing issues, what will be involved in implementing this massive legislation, what will change and what will not when it comes to health care?
The latest scapegoat of the left-EpiPen
The price of the EpiPen is not the real issue. Frankly I don’t know what the fair price is for an EpiPen or how the
Physicians, Patients, Insurance companies … guess Who Is The Bad Guy?
From some physicians perspectives insurance companies only want to squeeze them so they can make a bigger profit while at the same time shifting more
Premium increases? No problem says HHS🤑
According to a HHS release: An estimated 73 percent of HealthCare.gov consumers could still purchase a plan for less than $75 per month, even if
QUINNSCOMMENTARY 